As of Sep 2022 ยท from Yerbae' Common Stock 1 ยท pre-money + amount raised, not a traded price
Total raised
$1,172,803
Across 2 rounds since 2020
Latest share price
$1.37
Yerbae' Common Stock 1 offering price
Financials
FY2018โFY2022 ยท from SEC filings ยท hover any figure for its source
$1.9M
โ$2.0M
2018
$3.6M
โ$2.7M
2019
$4.8M
โ$1.5M
2020
$6.0M
โ$3.8M
2021
$7.2M
โ$9.1M
2022
RevenueNet income โ beside revenue when positive, below the line when a loss
Metric
FY2018
FY2019
FY2020
FY2021
FY2022
Income statement
Revenue
$1,887,808
$3,610,897
$4,780,045
$6,045,089
$7,166,847
Cost of goods sold
$1,463,647
$2,345,233
$1,805,106
$2,423,723
$2,952,273
Gross margin
22%
35%
62%
60%
59%
Net income
-$2,008,195
-$2,694,314
-$1,545,650
-$3,801,661
-$9,100,426
Taxes paid
$3,778
$674
$0
$0
$0
Balance sheet
Cash
$219,143
$542,633
$239,267
$347,806
$856,547
Accounts receivable
$20,171
$328,193
$385,198
$308,417
$922,725
Total assets
$727,495
$1,287,970
$1,043,230
$1,446,337
$3,371,333
Short-term debt
$2,953,437
$406,163
$1,357,073
$1,547,962
$8,212,892
Long-term debt
$928,876
$0
$350,000
$315,030
$576,795
Total liabilities
$3,882,313
$406,163
$1,707,073
$1,862,992
$8,789,687
Other
Headcount
โ
16
14
23
22
Figures as reported by the issuer in the filing shown on hover. Each yearโs pill shows the assurance level of its filed statements โ audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didnโt state one. Headcount is the filingโs point-in-time count, not a year-end average. Manually corrected figures are marked โCorrectedโ.
A dashed amber step is a SAFE/note valuation cap โ a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
About this data. Figures are compiled from public sources โ SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages โ and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.